Table 1 Patients’ characteristics in this study
Clinical parameters | Bladder cancer diagnosis | Recurrence diagnosis | ||
|---|---|---|---|---|
Bladder cancer | Benign | Recurrence | Non-recurrence | |
Age (years) | ||||
 < 60 | 1 (10%) | 15 (40.5%) | 2 (25%) | 20 (23.5%) |
 ≥ 60 | 9 (90%) | 22 (59.5%) | 6 (75%) | 65 (76.5%) |
Gender | ||||
 Male | 8 (80%) | 21 (56.8%) | 6 (75%) | 58 (68.2%) |
 Female | 2 (20%) | 16 (43.2%) | 2 (25%) | 27 (31.8%) |
Smoke status | ||||
 Never | 3 (30%) | 17 (46%) | 5 (62.5%) | 43 (50.6%) |
 Current | 1 (10%) | 5 (14%) | 2 (25%) | 20 (23.5%) |
 Unknown | 6 (60%) | 15 (40%) | 1 (12.5%) | 22 (25.9%) |
Grade | ||||
 Low | 2 (20%) | NA | 3 (37.5%) | NA |
 High | 6 (60%) | NA | 2 (25%) | NA |
 Unknown | 2 (20%) | NA | 3 (37.5%) | NA |
TNM | ||||
 Ta | 2 (20%) | NA | 4 (50%) | NA |
 T1 | 5 (50%) | NA | 0 (0%) | NA |
 T2 | 1 (10%) | NA | 1 (12.5%) | NA |
 Unknown | 2 (20%) | NA | 3 (37.5%) | NA |
CIS | ||||
 Yes | 2 (20%) | NA | 0 (0%) | NA |
 No | 6 (60%) | NA | 6 (75%) | NA |
 Unknown | 2 (20%) | NA | 2 (25%) | NA |
Tumor number | ||||
 Single | 4 (40%) | NA | 3 (37.5%) | NA |
 Multiple | 5 (50%) | NA | 2 (25%) | NA |
 Unknown | 1 (10%) | NA | 3 (37.5%) | NA |
Tumor size | ||||
 < 1.5 cm | 2 (20%) | NA | 0 (0%) | NA |
 ≥ 1.5 cm | 6 (60%) | NA | 3 (37.5%) | NA |
 Unknown | 2 (20%) | NA | 5 (62.5%) | NA |
Time from last TURBT to urine collection (month; median range) |  |  | 10.3 (3.9–100.5) | 9.4 (0.3–102.7) |
Number of confirmed recurrence | ||||
 Single |  |  | 3 (37.5%) | 60 (70.6%) |
 Multiple |  |  | 4 (50%) | 22 (25.9%) |
 Unknown |  |  | 1 (12.5%) | 3 (3.5%) |
Treatment type | ||||
 BCG |  |  | 1 (12.5%) | 15 (17.7%) |
 Bicin-kinds |  |  | 6 (75%) | 49 (57.7%) |
 GC |  |  | 0 (0%) | 12 (14.1%) |
 Others |  |  | 1 (12.5%) | 3 (3.5%) |
 Unknown |  |  | 0 (0%) | 6 (7%) |